Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT06909578

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
CorFlow Therapeutics AG (from the registry)
Registry
  • NCT NCT06909578
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06909578. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-09-01 (anticipated); primary completion 2026-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
Acronym
MOCA II
Condition
Microvascular Obstruction (MVO)
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Device)
CorFlow Controlled Flow Infusion System - CoFI™
Lead sponsor
CorFlow Therapeutics AG (class: industry)

Record details

Record id
cardio:ct-nct06909578
Content hash
185e577f369d87c31fca0391191cad8346b2fe9f9b0dbfa0cc0d0b458deb868a